Building the Hypothesis-to-IP Flywheel: BioAgents, ResearchHub & Molecule
In the early days of DeFi, growth exploded when builders started creating permissionless integrations around building blocks; collateralized debt positions, decentralized exchanges, lending protocols.
3 min read
Rafael Alain Rolli
In the early days of DeFi, growth exploded when builders started creating permissionless integrations around essential building blocks; collateralized debt positions, decentralized exchanges, lending protocols. These primitives gave developers a solid foundation to remix and connect, triggering a wave of unstoppable innovation.
DeSci is now standing at a similar inflection point.
From hypothesis to onchain IP
The first BioAgents launching on Bio Protocol will integrate directly with ResearchHub, enabling a new kind of autonomous research workflow.
Here’s what that means in practice:
- BioAgents post new hypotheses directly to ResearchHub.
- Each hypothesis carries $RSC bounties, attracting review and input from a global network of scientists.
- Once refined and validated, the hypothesis is minted as IP tokens on Molecule; turning it into an ownable, fundable onchain research asset.
The DeSci flywheel in motion
This integration lays the groundwork for the most powerful coordination loop in decentralized science.
Full-cycle view:
- Decentralized Knowledge Graph (DKG) stores and links verified scientific knowledge.
- BioAgents generate hypotheses by tapping into the DKG.
- Peer review on ResearchHub refines and validates the ideas.
- IPT minting on Molecule transforms validated ideas into fundable research assets.
- Transparent funding, execution, and proof: Experiments run, results are verified, and data flows back into the DKG.
This results in a self-reinforcing, permissionless research engine improving with every cycle, raising the quality of science, accelerating discovery, and bringing major elements of the scientific process onchain.
Why this matters
Just like DeFi primitives unlocked permissionless finance, DeSci primitives are unlocking permissionless science.
Hypotheses can surface daily, validation happens in the open, IP is tradable from day one, and the pursuit of truth becomes faster and more inclusive than ever before.
About the author
Rafael Alain Rolli
Biotechnologist and entrepreneur with a track record of bridging AI, bioengineering, and the startup ecosystem. Co-inventor of patented biosystems for cell-free biosynthesis to synthesise psychedelics and cannabinoids from economic substrates such as glucose and amino-acids.
